Log in
Enquire now
Amplyx Pharmaceuticals

Amplyx Pharmaceuticals

Amplyx Pharmaceuticals, Inc. is a preclinical stage company focusing on the development of small molecule drugs.

OverviewStructured DataIssuesContributors

Contents

amplyx.com
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Biology
Biology
Engineering
Engineering
Biomedical engineering
Biomedical engineering
Technology
Technology
Biotechnology
Biotechnology
Location
San Diego
San Diego
B2X
B2B
B2B
0
Legal Name
Amplyx Pharmaceuticals, Inc.
Number of Employees (Ranges)
11 – 500
Full Address
12730 High Bluff Drive, Suite 160, San Diego, CA 92130, US0
Investors
Pappas Capital
Pappas Capital
Arix Bioscience plc
Arix Bioscience plc
Ariel Savannah Angel Partners
Ariel Savannah Angel Partners
Sofinnova Partners
Sofinnova Partners
BioMed Ventures
BioMed Ventures
Pfizer
Pfizer
Lundbeckfonden Ventures
Lundbeckfonden Ventures
...
DUNS Number
780230004
Total Funding Amount (USD)
120,000,000
Latest Funding Round Date
May 19, 2020
Latest Funding Type
Series C
Series C
Patents Assigned (Count)
1
Country
United States
United States

Other attributes

Company Operating Status
Active
Latest Funding Round Amount (USD)
53,000,000
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Amplyx Pharmaceuticals

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.